Xinchun Chen

Guangdong Provincial Key Laboratory Of Infection Immunity And Inflammation
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Mycobacterium tuberculosis Rv3875 upregulates TRIM21 expression through the type I interferon/STAT1 pathway and promotes intracellular growth.

Mycobacterium tuberculosis Rv3875 upregulates TRIM21 expression through the type I interferon/STAT1 pathway and promotes intracellular growth.

Journal: Microbial pathogenesis
Published: March 31, 2026

Transcriptomic signatures predict severe linezolid-induced peripheral neuropathy and reveal pre-treatment immune and antioxidant dysregulation.

Transcriptomic signatures predict severe linezolid-induced peripheral neuropathy and reveal pre-treatment immune and antioxidant dysregulation.

Journal: Tuberculosis (Edinburgh, Scotland)
Published: December 16, 2025

Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China.

Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China.

Journal: BMC infectious diseases
Published: November 15, 2025

Mycobacterium tuberculosis IDH-PPARγ interaction suppresses GPX4 to drive macrophage ferroptosis and sustain persistent infection.

Mycobacterium tuberculosis IDH-PPARγ interaction suppresses GPX4 to drive macrophage ferroptosis and sustain persistent infection.

Journal: Nature communications
Published: July 16, 2025

UMPlex™: a targeted next-generation sequencing primer design workflow.

UMPlex™: a targeted next-generation sequencing primer design workflow.

Journal: Virology journal
Published: February 13, 2025

Elevated PD-1 and PDL-1 autoantibodies and association with tuberculosis.

Elevated PD-1 and PDL-1 autoantibodies and association with tuberculosis.

Journal: The Journal of infection
Published: January 05, 2025

Assessing the risk of TB progression: Advances in blood-based biomarker research.

Assessing the risk of TB progression: Advances in blood-based biomarker research.

Journal: Microbiological research
Published: September 04, 2024

Plasma miRNA signature for the diagnosis of pulmonary tuberculosis in symptomatic patients.

Plasma miRNA signature for the diagnosis of pulmonary tuberculosis in symptomatic patients.

Journal: Thorax
Published: July 06, 2024

Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

Nutritional supplementation for tuberculosis prevention: the RATIONS trial.

Journal: Lancet (London, England)
Published: October 31, 2023

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR].

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR].

Journal: BMC infectious diseases
Published: August 30, 2023

Low levels of humoral response to monkeypox virus-specific antigens in healthy individuals.

Low levels of humoral response to monkeypox virus-specific antigens in healthy individuals.

Journal: The Journal of infection
Published: March 31, 2023

Corrigendum to 'single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis' [EBioMedicine 53 (2020) 102686].

Corrigendum to 'single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis' [EBioMedicine 53 (2020) 102686].

Journal: EBioMedicine
Published: March 01, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026